Abstract
Programmed cell death is an integral part of the mechanisms regulating tissue homeostasis. Defects in the apoptotic signaling pathway are often associated with uncontrolled cell proliferation, high mutation rate and malignant transformation. Transcription factors, such as the mammalian ATF/CREB family of transcriptional regulators, have diverse functions in controlling cell proliferation and apoptosis. One particular ATF/CREB family member, ATFx, is an anti-apoptotic factor that plays an essential role in cell survival. Current observations indicate that one mechanism by which ATFx inhibits cell death and promotes cell survival is by disrupting signal transmission from activated “death receptors” to initiator caspases. A better understanding of ATFx function should provide new insight into the processes that control apoptotic cascades.
Similar content being viewed by others
References
Green DR, Evan GI. A matter of life and death. Cancer Cell 2002; 119–30.
Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: A link between cancer genetics and chemotherapy. Cell 2002; 108153–164.
Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999; 96245–254.
Williams GT. Programmed cell death: Apoptosis and oncogenesis. Cell 1991; 651097–1098.
Sherr CJ. Cancer cell cycles. Science 1996; 2741672–1677.
Engel I, Murre C. The function of E-and Id proteins in lymphocyte development. Nat Rev Immunol 2001; 1193–199.
Hasskarl J, Munger K. Id proteins-Tumor markers or oncogenes? Cancer Biol Ther 2002; 191–96.
Hickman ES, Moroni MC, Helin K. The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev 2002; 1260–66.
Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 2821497–1501.
Zhang HS, Postigo AA, Dean DC. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition. Cell 1999; 9753–61.
Muller H, Bracken AP, Vernell R, et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 2001; 15267–285.
Juin P, Hueber AO, Littlewood T, Evan G. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev 1999; 131367–1381.
Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 2661821–1828.
Persengiev SP, Devireddy LR, Green MR. Inhibition of apoptosis byATFx:Anovel role for a member of theATF/CREB family of mammalian bZIP transcription factors. Genes Dev 2002; 161806–1814.
Peters CS, Liang X, Li S, et al. ATF-7, a novel bZIP protein, interacts with the PRL-1 protein-tyrosine phosphatase. J Biol Chem 2001; 27613718–13726.
Cory S, Adams JM. The Bcl2 family: Regulators of the cellular life-or-death switch. Nature Rev Cancer 2002; 2647–656.
Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335440–442.
Hai TW, Liu F, Coukos WJ, Green MR. Transcription factor ATF cDNA clones: An extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev 1989; 32083–2090.
Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U. ATF3 and stress responses. Gene Expr 1999; 7321–335.
Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model. Oncogene 2000; 194011–4021.
Hai T, Hartman MG. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: Activating transcription factor proteins and homeostasis. Gene 2001; 2731–11.
De Cesare D, Sassone-Corsi P. Transcriptional regulation by cyclic AMP-responsive factors. Prog Nucleic Acid Res Mol Biol 2000; 64343–369.
Pati D, Meistrich ML, Plon SE. Human Cdc34 and Rad6B ubiquitin-conjugated enzymes target repressors of cyclic AMPinduced transcription for proteolysis. Mol Cell Biol 1999; 195001–5013.
Devireddy LR, Teodoro JG, Richard FA, Green MR. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 2001; 293829–834.
Bleckmann SC, Blendy JA, Rudolph D, Monaghan AP, Schmid W, Schutz G. Activating transcription factor 1 and CREB are important for cell survival during early mouse development. Mol Cell Biol 2002; 221919–1925.
Bhoumik A, Huang TG, Ivanov V, et al. An ATP2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 2002; 110643–650.
Echlin DR, Tae HJ, Mitin N, Taparowsky EJ. B-ATF function as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Oncogene 2000; 191752–1763.
Mashima T, Udagawa S, Tsuruo T. Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis. J Cell Physiol 2001; 188352–358.
Zhang C, Kawauchi J, Adachi MT, et al. Activation of JNK and transcriptional repressor ATF3/LRF1 trough the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem Biophys Res Commun 2001; 289718–724.
Kawauchi J, Zhang C, Nobori K, et al. Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription. J Biol Chem 2002; 27739025–39034.
Hettmann T, Barton K, Leiden JM. Microphthalmia due to p53-mediated apoptosis of anterior lens epithelial cells in mice lacking the CREB-2 transcription factor. Dev Biol 2000; 222110–123.
Masuoka HC, Townes TM. Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice. Blood 2002; 99736–745.
Oyadomari S, Araki E, Mori M. Endoplasmic reticulum stressmediated apoptosis in pancreatic beta-cells. Apoptosis 2002; 7335–345.
Gotoh T, Oyadomari S, Mori K, Mori M. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP. J Biol Chem 2002; 27712343–12350.
Binaschi M, Capranico G, Dal Bo L, Zunino F. Relationship between lethal effects and topoisomerase II-mediated doublestranded DNA breaks produced by anthracyclines with different sequence specificity. Mol Pharmacol 1997; 511053–1059.
Green DR. Apoptotic pathways: Paper wraps stone blunts scissors. Cell 2000; 1021–4.
Green DR. Apoptotic pathways: The road to ruin. Cell 1998; 94695–698.
Collins MK, Perkins GR, Rodriguez-Tarduchy G, Nieto MA, Lopez-Rivas A. Growth factors as survival factors: Regulation of apoptosis. Bioessays 1994; 16133–138.
Pardee AB.G1events and regulation of cell proliferation. Science 1989; 246603–608.
Palacios R, Garland J. Distinct mechanisms may account for the growth-promoting activity of interleukin 3 on cells of lymphoid and myeloid origin. Proc Natl Acad Sci USA 1984; 811208–1211.
Whetton AD, Bazill GW, Dexter TM. Haemopoietic cell growth factor mediates cell survival via its action on glucose transport. EMBO J 1984; 3409–413.
Gonin-Giraud S, Mathieu AL, Diocou S, Tomkowiak M, Delorme G, Marvel J. Decreased glycolytic metabolism contributes to but is not the inducer of apoptosis following IL-3 starvation. Cell Death Differ 2002; 91147–1157.
Garland J, Halestrap A. Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest. J Biol Chem 1997; 2724680–4688.
Khaled AR, Reynolds DA, Young HA, Thompson CB, Muegge K, Durum SK. Interleukin-3 withdrawal induces an early increase in mitochondrial membrane potential unrelated to the Bcl-2 family. Roles of intracellular pH, ADP transport, and F(0)F(1)-ATPase. J Biol Chem 2001; 2766453–6462.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Persengiev, S.P., Green, M.R. The role of ATF/CREB family members in cell growth, survival and apoptosis. Apoptosis 8, 225–228 (2003). https://doi.org/10.1023/A:1023633704132
Issue Date:
DOI: https://doi.org/10.1023/A:1023633704132